Latest news
Loading news…
Raven Biotechnologies
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). South San Francisco, California, United States Founded 1999 51-100 employees For Profit
Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.
Raven Biotechnologies was acquired by MacroGenics in 2008.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
3
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Patents granted
- 3
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $3M
Company Info
- Founded
- 1999
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 3
- HQ
- South San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Diversity spotlight
- Women Founded
- Exit date
- Jul 17, 2008
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.1
- Trend (30d)
- 0
- Trend (90d)
- 4.4
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Raven Biotechnologies
Loading news…
FAQs about Raven Biotechnologies
People who checked this page also checked these
Browse the full Acquirezy directory.